MEDMIX AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.22 CHF | +1.20% |
|
+1.06% | -19.89% |
| 04-17 | AARDEX Group announced that it has received funding from medmix AG | CI |
| 04-16 | Medmix Unit Enters Japanese Distribution Deal for PiccoJect Product | MT |
ETFs positioned on medmix AG
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 152 M€ | -3.56% | - | |
| 0.00% | 26 M€ | -4.70% | - | |
| 0.00% | 1 M€ | -.--% | - | |
| 0.00% | 29 M€ | -3.53% | - |
Medmix Systems AG is a Switzerland-based company active in manufacturing of high-precision delivery devices. The Company operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
Calendar
2024-07-17
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.22
CHF
Average target price
30
CHF
Spread / Average Target
+97.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.89% | 679M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- MEDX Stock
- Funds and ETFs medmix AG
